116 related articles for article (PubMed ID: 3759371)
1. Thymidine kinase activity of ocular herpes simplex isolates resistant to IUDR therapy.
Funderburgh ML; Funderburgh JL; Chandler JW
Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1546-8. PubMed ID: 3759371
[TBL] [Abstract][Full Text] [Related]
2. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
[TBL] [Abstract][Full Text] [Related]
3. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
5. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
6. Cross-resistances to antiviral drugs of IUdR-resistant HSV1 in rabbit keratitis and in vitro.
Fardeau C; Langlois M; Nugier F; Asselot C; Aymard M; Denis J
Cornea; 1993 Jan; 12(1):19-24. PubMed ID: 8384543
[TBL] [Abstract][Full Text] [Related]
7. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
8. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
12. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
[TBL] [Abstract][Full Text] [Related]
13. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
[TBL] [Abstract][Full Text] [Related]
14. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
[TBL] [Abstract][Full Text] [Related]
15. Biochemical classification of herpes simplex virus types 1 and 2, and of intermediate strains on the basis of different susceptibilities of thymidine kinase to thymidine analogues.
Just I; Dundaroff S; Falke D
Acta Virol; 1976 Feb; 20(1):31-9. PubMed ID: 7938
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of feline and canine herpesvirus thymidine kinase.
Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
Morfin F; Thouvenot D; Aymard M; Souillet G
J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
[TBL] [Abstract][Full Text] [Related]
19. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis.
Fardeau C; Langlois M; Mathys B; Rafales P; Nugier F; Godard V; Aymard M; Denis J
Curr Eye Res; 1991; 10 Suppl():151-8. PubMed ID: 1650663
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.
Sarisky RT; Cano R; Nguyen TT; Wittrock RJ; Duffy KE; Clark P; Bartus JO; Bacon TH; Caspers-Velu L; Hodinka RL; Leary JJ
Clin Infect Dis; 2001 Dec; 33(12):2034-9. PubMed ID: 11712095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]